Pharvaris N.V. PHVS
32.02
(0.97)
(2.94%)
as of 25 Sep
- Market cap
- $2.3B
- P/E
- 0.0×
Follow PHVS
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Current Ratio |
11.94 | 11.24 | 10.11 | 12.86 |
+8 more quarters Free account |
Net Debt/EBITDA |
6.28 | 5.58 | 5.95 | 8.31 | |
Debt/Assets |
0.15% | 0.20% | 0.19% | 0.13% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.78 | 1.24 | 0.71 | 0.88 | |
Capex/Depreciation |
(0.15) | (0.50) | 0.04 | (0.21) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(0.64) | (0.87) | (0.66) | (0.61) | |
Cash per Share |
5.44 | 4.43 | 5.58 | 6.18 | |
Shareholders Equity per Share |
5.14 | 4.24 | 5.19 | 5.86 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
5.14 | 4.24 | 5.19 | 5.86 | |
Free Cash Flow |
(43.61) | (57.14) | (39.22) | (38.18) | |
Working Capital |
348.23 | 274.76 | 304.98 | 363.50 | |
Capital Expenditures |
(0.03) | (0.06) | 0.00 | (0.03) | |
Net Current Asset Value |
347.67 | 274.14 | 304.33 | 362.98 | |
| Other line items | |||||
Quick Ratio |
11.82 | 10.99 | 10.01 | 12.67 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.64) | (0.87) | (0.66) | (0.61) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Receivables |
4.54 | 4.30 | 4.17 | 3.22 | |
Average Payables |
4.38 | 3.81 | 5.36 | 3.80 | |
Average Assets |
310.16 | 282.70 | 328.18 | 370.25 | |
Average Common Equity |
279.51 | 257.00 | 298.33 | 345.66 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates